Neglected European stocks set to soar
Europe hasn't been the investors' location of choice recently. But now European stocks, having lagged behind the US since March, may be set to outperform.
Contrarians will warm to a sector where there is "an absence of enthusiasm of any kind", says Tim Price of PFP Wealth Management.
Enter Europe: as Barry Norris of Argonaut Capital Partners points out, net flows into European equity funds have been negative for the past two years. Morgan Stanley notes that at a recent conference, just 19% of investors chose Europe as their favourite investment region while 42% plumped for the US.
On top of that, Europe is also trading at close to a 35-year low relative to US equities in terms of a composite valuation measure including the price/book-value ratio and dividend yields. Citigroup says that pan-Europe's price/book is close to mid-1990s levels.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
So European stocks, having lagged behind the US since March, may be set to outperform. Short-term risks abound, but as Warren Buffett says, "the time to get interested is when no one else is".
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge